The National Highway Traffic Safety Administration (NHTSA) has rejected Ford Motor Co's petition against recalling 3 million vehicles with potentially defective Takata airbags.
The auto safety agency's decision also will require Mazda to recall and repair driver airbags in approximately 5,800 vehicles.
The Ford vehicles that will be recalled include Edge, Fusion, Ranger, Lincoln Zephyr/MKZ, Lincoln MKX, and Mercury Milan vehicles, along with Mazda 2007–2009 model year B-Series vehicles.
It was found that the Takata airbag inflators could rupture and send potentially deadly metal fragments flying, especially after extensive exposure to high humidity.
It prompted the largest automotive recall in US history of more than 67 million inflators.
There were about 100 million inflators installed by 19 major automakers that have been recalled worldwide.
Earlier this month, the NHTSA said at least 17 million vehicles with Takata airbags remain unrepaired.
Ruptures of Takata inflators have resulted in 18 fatalities in the US and at least 27 people in other parts of the world, and more than 400 reported injuries.
Two people died due to airbag ruptures in 2006 Ford Ranger vehicles with the most recent being in 2017. The vehicles involved were earlier recalled.
In November, the NHTSA also rejected a petition filed by General Motors Co to avoid recalling 5.9 million US vehicles with Takata airbags.
GM estimated that the recalls would cost $1.2 billion if it were required to replace airbag inflators.


Thailand Inflation Remains Negative for 10th Straight Month in January
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 



